3D Signatures Inc. appointed Dr. Kevin Little new Chief Scientific Officer, effective immediately. In this role, Dr. Little will oversee the design, development and implementation of the Company’s clinical programs. Dr. Little is an accomplished industry executive with a strong history of success in leading life sciences ventures through the creation of collaborative business ecosystems. Prior to his position at 3DS, Dr. Little worked as an independent consultant, offering strategic advisory services to help facilitate new life sciences collaborations and research-related ecosystems for public and private sector clients, including Thomson Reuters, Illumina, Janssen, McGill University and the Global Alliance for Genomics and Health.